1001 - IgM Monoclonal Gammopathy Arises Directly from MBL/CLL Cells: Evidence from Proteomic Analyses

Primary Author(s)

Uday Aditya Sarkar, PhD

Research Fellow
Dana-Farber Cancer Institute, Harvard Medical School
Boston, Massachusetts, United States

Co-Author(s)

DT

Dylan Nicholas Tabang, PhD

Research Fellow
Boston Children's Hospital, Harvard Medical School
Boston, Massachusetts, United States
CM

Colin McNulty, BS

Research Technician
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
SA

Sabine Allam, MD

Research Fellow
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
AU

Ayazhan Umutbayeva, MD

Medical Fellow
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
SF

Stacey M. Fernandes, BS

Department of Medical Oncology, Dana-Farber Cancer Institute
Boston, Massachusetts, United States
MM

Mariia Mikhaleva, MD

Medical Fellow
Medical Oncology, Dana-Farber Cancer Institute
Boston, Massachusetts, United States
RS

Roberta Santos Azevedo, MD

Medical Fellow
The University of Texas MD Anderson Cancer Center
Houston, Texas, United States
ZW

Zainab Wurie, BS

Research Technician
Boston Children's Hospital
Boston, Massachusetts, United States
AB

Ava Bidgoli, BS

Research Technician
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
NO

Natalie Oliveira Onofri, BS

Research Technician
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
JF

Joseph Casey Flinn, BS

Research Technician
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Kiyomi Mashima, MD, PhD

Research Fellow
Dana-Farber Cancer Institute, Harvard Medical School
Boston, Massachusetts, United States
IL

Ingrid Lourme, BS

Research Fellow
Boston Children's Hospital
Boston, Massachusetts, United States
EV

Elsa Vlachonikola, PhD

Research Fellow
Institute of Applied Biosciences, Centre for Research and Technology Hellas
Thessaloniki, Thessaloniki, Greece
BK

Binu Kandathilparambil Sasi, PhD

Research Fellow
Dana-Farber Cancer Institute, Harvard Medical School
Boston, Massachusetts, United States
PP

Paulina Predko, BS

Clinical Research Co-ordinator
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
AA

Andreas Agathangelidis, PhD

Principal Investigator
Division of Genetics and Biotechnology, Department of Biology, National and Kapodistrian University
Athens, Attiki, Greece
KP

Kenneth Parker, PhD

Senior Researcher
Boston Children's Hospital
Boston, Massachusetts, United States
Kostas Stamatopoulos, MD, PhD

Principal Investigator
Institute of Applied Biosciences, Centre for Research and Technology Hellas
Thessaloniki, Thessaloniki, Greece
IG

Irene M. Ghobrial, MD, PhD

Principal Investigator
Dana-Farber Cancer Institute, Harvard Medical School
Boston, Massachusetts, United States
Jennifer R. Brown, MD, PhD

Director, CLL Center, and Institute Physician; Worthington Margaret Collette Professor of Medicine in the Field of Hematologic Oncology
Dana-Farber Cancer Institute, Harvard Medical School
Boston, Massachusetts, United States
HS

Hanno Steen, PhD

Principal Investigator
Boston Children's Hospital, Harvard Medical School
Boston, Massachusetts, United States

Primary Author / Presenter(s)

Paolo Ghia, MD, PhD

Professor of Medical Oncology
Università Vita Salute and IRCCS Ospedale San Raffaele
Milano, Lombardia, Italy